GSK
GSK
GSK
791 hedge funds and large institutions have $12.4B invested in GSK in 2021 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 297 increasing their positions, 231 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% less funds holding
Funds holding: 798 → 791 (-7)
3% less capital invested
Capital invested by funds: $12.7B → $12.4B (-$357M)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
Holders
791
Holding in Top 10
13
Calls
$327M
Puts
$163M
Top Buyers
| 1 | +$129M | |
| 2 | +$125M | |
| 3 | +$73.7M | |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$47.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$19.5M |
Top Sellers
| 1 | -$147M | |
| 2 | -$60.7M | |
| 3 | -$43.1M | |
| 4 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$41.7M |
| 5 |
BCAM
Boston Common Asset Management
Boston,
Massachusetts
|
-$28.4M |